Long-lasting, late-onset, and chronic idiopathic neutropenia project

An SWG Grant-supported project initiated by EHA’s Granulocytes and Constitutional Marrow Failure Disorders SWG.  

Project team 

Dr Francesca Fioredda 
Senior Hematologist  Giannina Gaslini Children's Hospital  Italy 
Dr Grigorios Tsaknakis 
Post-doctoral researcher, Prof Dr Helen Papadaki’s Haemopoiesis Research Lab, School of Medicine  University of Crete  Greece 

Project background and aims 

This SWG Grant-funded project will help to support an increased knowledge of LLNp, LONp, and CIN.   

Neutropenia is a condition that affects the number of neutrophils in a person’s blood, resulting in a low number of these white blood cells.  

There are two types of neutropenia that are not categorized as either primary autoimmune neutropenia or the idiopathic neutropenia of infancy. 

These are:  

  • Long-lasting neutropenia (LLNp)—which is a type of neutropenia that lasts for more than the typical period of 24 to 36 months  
  • Late-onset neutropenia (LONp)—which is a type of neutropenia that has a delayed or a very delayed onse

Both types of neutropenia:  

  • Are sometimes diagnosed by chance, due to the very mild clinical phenotype  
  • Do not usually show remission  

As shown in a recent paper from our group, both forms might be considered as a unique entity that’s sustained, at least in a little subgroup, by an underlying genetic background.  

In both cases, patients show signs of immune dysregulation. This may be present at the beginning, with a tendency to worsen over time (leukopenia, lymphopenia with decreased B and NK cell numbers).  

We could speculate that, because they present few symptoms, neutropenias that arise in late infancy or adolescence may be under-diagnosed until adulthood. At that point, they will present as chronic idiopathic neutropenia (CIN).  

If this hypothesis is correct, there could be a link that joins neutropenia in children with neutropenia in adults. In this view, any collaboration between pediatricians and adult hematologists is of outstanding importance.  

This SWG Grant-funded project will help to create the basis of that connection by supporting increased knowledge of LLNp, LONp, and CIN.  

In particular, it will provide information on their:  

  • Clinical and immunological features  
  • Genetic background, through the application of the whole-exome sequencing (WES) technique 

By furthering knowledge on LLNp, LONp, and CIN, we can help clinicians to:  

  • Understand the underlying mechanisms of these disorders  
  • Tailor diagnostic workups  
  • Manage affected patients more appropriately 

 The research hypothesis is that:  

  • A constitutional/congenital background might exist in some CIN cases  
  • The CIN phenotype can be also an epiphenomenon of immune dysregulation and associated underlying disorders 

This grant will significantly contribute towards delineating the pathogenesis of CIN through the:  

  • Identification of variants with high probability to display a causative role  
  • Indication of a potential continuum in the spectrum of CIN from childhood to adulthood, at least in some cases  
  • Identification of cases with common genetic background

Project updates

You can find out more about the status of this project by reading the latest update from Dr Grigorios Tsaknakis.